Neurogene Inc
NASDAQ: NGNENew York, US · Founded 2018 · Delaware corporation · 1 known investors
Accelerating development of new genetic medicines for people with devastating neurological diseases.
Founders & leadership
CF
Cory FreedlandDirector
RM
Rachel McMinnExecutive Officer, Director
SB
Stephen BiggarDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$69MraisedDec 2020 · 32 investors · OtherRule 506(b)
▶$69MraisedDec 2020 · 32 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Rachel McMinnExecutive Officer, Director
- Christine Mikail CvijicExecutive Officer
- Robert BaffiDirector
- Caroline StoutDirector
- Cory FreedlandDirector
- Srdjan StankovicDirector
- Stephen BiggarDirector
- Offering amount
- $115M
- Amount sold
- $69M
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$37.5MraisedFeb 2019 · 13 investors · OtherRule 506(b)
▶$37.5MraisedFeb 2019 · 13 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Cory FreedlandDirector
- Rachel McMinnExecutive Officer, Director
- Stephen BiggarDirector
- Offering amount
- $37.5M
- Amount sold
- $37.5M
- First sale
- Feb 2019
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.